Cargando…

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

BACKGROUND: To assess the safety and efficacy of Stereotactic Ablative Radiotherapy (SABR) in oligometastatic patients from colorectal cancer. METHODS: 82 patients with 1–3 inoperable metastases confined to one organ (liver or lung), were treated with SABR for a total of 112 lesions in an observatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comito, Tiziana, Cozzi, Luca, Clerici, Elena, Campisi, Maria Concetta, Liardo, Rocco Luca Emanuele, Navarria, Pierina, Ascolese, AnnaMaria, Tozzi, Angelo, Iftode, Cristina, De Rose, Fiorenza, Villa, Elisa, Personeni, Nicola, Rimassa, Lorenza, Santoro, Armando, Fogliata, Antonella, Mancosu, Pietro, Tomatis, Stefano, Scorsetti, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165935/ https://www.ncbi.nlm.nih.gov/pubmed/25163798 http://dx.doi.org/10.1186/1471-2407-14-619

Ejemplares similares

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013)

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients
por: Alongi, Filippo, et al.
Publicado: (2012)

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy
por: Tozzi, Angelo, et al.
Publicado: (2014)

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018)

11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity
por: Alongi, Filippo, et al.
Publicado: (2014)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
por: Alongi, Filippo, et al.
Publicado: (2013)

Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease
por: Franceschini, Davide, et al.
Publicado: (2016)

Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection
por: Navarria, Pierina, et al.
Publicado: (2016)

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
por: De Rose, Fiorenza, et al.
Publicado: (2016)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc
por: Scorsetti, Marta, et al.
Publicado: (2010)

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
por: Navarria, Pierina, et al.
Publicado: (2016)

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015)

Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case
por: Lobefalo, Francesca, et al.
Publicado: (2013)

Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022)

In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study
por: Mancosu, Pietro, et al.
Publicado: (2015)

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020)

Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases
por: Pessina, Federico, et al.
Publicado: (2016)

Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments
por: Scorsetti, Marta, et al.
Publicado: (2011)

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma
por: Scorsetti, Marta, et al.
Publicado: (2015)

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma
por: Cozzi, Luca, et al.
Publicado: (2019)

Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation
por: Fogliata, Antonella, et al.
Publicado: (2015)

Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique
por: Mancosu, Pietro, et al.
Publicado: (2012)

Cone beam CT pre‐ and post‐daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer
por: Reggiori, Giacomo, et al.
Publicado: (2010)

Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021)

Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate
por: Cozzi, Luca, et al.
Publicado: (2018)

Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin’s lymphoma. Assessment of risk of toxicity and secondary cancer induction
por: Scorsetti, Marta, et al.
Publicado: (2020)

On the gEUD biological optimization objective for organs at risk in Photon Optimizer of Eclipse treatment planning system
por: Fogliata, Antonella, et al.
Publicado: (2017)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations
por: Mancosu, Pietro, et al.
Publicado: (2012)

RapidPlan head and neck model: the objectives and possible clinical benefit
por: Fogliata, A., et al.
Publicado: (2017)

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
por: Navarria, Pierina, et al.
Publicado: (2017)

Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
por: Franzese, Ciro, et al.
Publicado: (2023)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
por: Comito, Tiziana, et al.
Publicado: (2023)

Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients
por: Scorsetti, Marta, et al.
Publicado: (2010)

On the robustness of VMAT-SABR treatment plans against isocentre positioning uncertainties
por: Stroom, Joep, et al.
Publicado: (2014)

SABR in oligometastatic breast cancer: Current status and future directions
por: Stewart, Rachel, et al.
Publicado: (2021)

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
por: Comito, Tiziana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_em94bqcd5045ugd0olnuoglcpi